Physician profile

Marc A Levin

Neurological Surgery · Munster, IN

NPI 1619952470

$672.66

in general payments reported to CMS, 2019-2025

19 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$95.24

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kuros Biosciences USA, INC $95.24 2023
Orthofix Medical, INC. $74.05 2019-2021
Varian Medical Systems, INC. $73.71 2019
Medtronic USA, INC. $71.39 2019
Stryker Corporation $65.90 2019-2021
Chiesi USA, INC. $38.57 2019-2022
Boston Scientific Corporation $31.54 2019
Depuy Synthes Sales INC. $30.19 2019
Medtronic, INC. $25.08 2021
Djo, LLC $24.91 2022
Ethicon US, LLC $19.65 2019
Natus Medical Incorporated $19.06 2019
Arbor Pharmaceuticals, INC. $18.26 2019
Abbott Laboratories $17.44 2019
Integra Lifesciences Corporation $15.70 2019
Show all 19 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $14.82 2019
Zimmer Biomet Holdings, INC. $13.93 2019
Misonix INC $13.17 2019
Si-Bone, INC. $10.05 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marc A Levin

$672.66

in general payments reported 2019-2025

Years
2019-2023
Top company
Kuros Biosciences USA, INC

https://glasscript.com/doctor/72749/marc-a-levin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.